Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5174165
Max Phase: Preclinical
Molecular Formula: C42H56N4O15
Molecular Weight: 856.92
Associated Items:
ID: ALA5174165
Max Phase: Preclinical
Molecular Formula: C42H56N4O15
Molecular Weight: 856.92
Associated Items:
Canonical SMILES: CO[C@@H]1[C@@H](O)[C@@H](OC)[C@H](Oc2cccc3c2C(=O)N([C@@]2(C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4ccc(O)cc4)[C@H](O)CC(N)=O)C[C@@H]2C)[C@H]3CCCCCCCC(=O)O)O[C@@H]1C
Standard InChI: InChI=1S/C42H56N4O15/c1-21-20-42(21,41(57)45-33(27(48)19-29(43)49)37(53)44-32(39(55)56)23-15-17-24(47)18-16-23)46-26(12-8-6-5-7-9-14-30(50)51)25-11-10-13-28(31(25)38(46)54)61-40-36(59-4)34(52)35(58-3)22(2)60-40/h10-11,13,15-18,21-22,26-27,32-36,40,47-48,52H,5-9,12,14,19-20H2,1-4H3,(H2,43,49)(H,44,53)(H,45,57)(H,50,51)(H,55,56)/t21-,22+,26-,27+,32-,33-,34+,35-,36+,40-,42-/m0/s1
Standard InChI Key: KSNXJKZMCLXJGX-IAPBWORRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 856.92 | Molecular Weight (Monoisotopic): 856.3742 | AlogP: 1.66 | #Rotatable Bonds: 22 |
Polar Surface Area: 293.81 | Molecular Species: ACID | HBA: 13 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.31 | CX Basic pKa: | CX LogP: 1.52 | CX LogD: -4.57 |
Aromatic Rings: 2 | Heavy Atoms: 61 | QED Weighted: 0.08 | Np Likeness Score: 0.91 |
1. Hwang GJ, Jang M, Son S, Kim GS, Lee B, Heo KT, Kim GJ, Choi H, Hur JS, Jang JP, Ko SK, Hong YS, Ahn JS, Jang JH.. (2022) Ulleungdolin, a Polyketide-Peptide Hybrid Bearing a 2,4-Di-O-methyl-β-d-antiarose from Streptomyces sp. 13F051 Co-cultured with Leohumicola minima 15S071., 85 (10.0): [PMID:36197044] [10.1021/acs.jnatprod.2c00682] |
Source(1):